ABEO

Abeona Therapeutics Inc.

7.68 USD
-0.13 (-1.66%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Abeona Therapeutics Inc. stock is up 79.02% since 30 days ago. The next earnings date is Mar 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 8 March’s closed higher than February. In the last 3 Unusual Options Trades, there were 3 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
21 Feb 17:39 21 Jun, 2024 7.50 CALL 249 276
04 Mar 14:53 20 Dec, 2024 10.00 CALL 309 64
04 Mar 14:53 21 Jun, 2024 10.00 CALL 327 16

About Abeona Therapeutics Inc.

Abeona Therapeutics Inc. develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A.